KNTPF 财务： Kintor Pharmaceutical Limited AI 分析

Q: 技术分析指标如何适用于 KNTPF？

根据技术分析，Kintor Pharmaceutical Limited 的综合信号为 Sell。Kintor Pharmaceutical Limited 有 1 个买入信号，4 个中性信号和 2 个卖出信号。

Q: KNTPF 的斐波那契回调水平是多少？

Kintor Pharmaceutical Limited 的斐波那契回调水平是 在 78.6% 和 100% 之间。

Q: Kintor Pharmaceutical Limited 的 RSI 是多少？

Kintor Pharmaceutical Limited 的 RSI 目前为 68.57，表明处于 中立 状态

Q: Kintor Pharmaceutical Limited 接下来 12 个月的价格是多少？

Kintor Pharmaceutical Limited KNTPF 接下来 12 个月的价格预计为 $1.28。

Q: Kintor Pharmaceutical Limited 预计会涨到多高？

据华尔街分析师称，Kintor Pharmaceutical Limited 预计将达到 $1.55 的高预测值。

主页

股票

KNTPF

预测

KNTPF 股票价格预测

Kintor Pharmaceutical Limited

$0.34

收盘价：Jan 23, 16:00:00 GMT-5

$0.34

盘后：Jan 23, 20:00:00 GMT-5

概述预测收益股息财务数据

关键数据

前收盘价

$0.3492

开盘价

$0.2588

当日区间

$0.2588 - $0.3492

52周范围

$0.1441 - $0.3643

交易量

460

平均成交量

每股收益（TTM）

-0.05

股息收益率

市值

$163.7M

什么是 KINTOR PHARMACEUTICAL LTD.？

Kintor Pharmaceutical Ltd. is a clinical-stage novel drug developer in China, which engages in the proprietary research and development of innovative medicine products for cancers and other Androgen receptor-related diseases. The company is headquartered in Suzhou, Jiangsu and currently employs 136 full-time employees. The company went IPO on 2020-05-22. The firm's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The firm has two core drugs in the dermatology field, KX-826 and GT20029. The firm's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.

功能特性

交易策略

资源

市场

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for KNTPF in the upcoming periods. Looking toward the future, our 2024 projection indicates an average price target of $1.28. The lowest target is $1.11 and the highest is $1.55. Empower your investment choices with our cutting-edge, data-driven analysis!

KNTPF 股价预测摘要

KNTPF的顶级分析师评级

基于 7 位分析师对 KNTPF 的股票评级，更新于 Apr 01, 2024

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for KNTPF. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: KNTPF is a Buy candidate.

KNTPF stock price ended at $0.35 on 星期三, after rising 6.06%

On the latest trading day Jan 21, 2026, the stock price of KNTPF rose by 6.06%, climbing from $0.35 to $0.35. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.35 and a high of $0.35. Notably, trading volume dropped by 103 shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 603 shares were traded, equating to a market value of approximately $164.1M.

KNTPF 技术面信号

技术面信号摘要

购买信号 1

中性信号 4

卖出信号 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

KNTPF目前显示1个买入信号和2个卖出信号。该股票自12:00 AM以来一直处于上升趋势状态，在此期间价格总变动为59.09%。总体而言，技术指标显示中期前景为Sell。

KNTPF 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 KNTPF 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 KNTPF？



KNTPF 的斐波那契回调水平是多少？



Kintor Pharmaceutical Limited 的 RSI 是多少？



Kintor Pharmaceutical Limited 接下来 12 个月的价格是多少？



Kintor Pharmaceutical Limited 预计会涨到多高？



Kintor Pharmaceutical Limited（KNTPF）价格

KNTPF 股价走势图